Christopher Farrell

3.5k total citations
27 papers, 272 citations indexed

About

Christopher Farrell is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Christopher Farrell has authored 27 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Christopher Farrell's work include Cancer Genomics and Diagnostics (4 papers), Genetic factors in colorectal cancer (4 papers) and Pharmaceutical studies and practices (3 papers). Christopher Farrell is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Genetic factors in colorectal cancer (4 papers) and Pharmaceutical studies and practices (3 papers). Christopher Farrell collaborates with scholars based in United States, India and Canada. Christopher Farrell's co-authors include Phillip Buckhaults, Jeffrey R. Lee, Ying Lin, Robert H. Podolsky, William S. Dynan, Robert R. Schade, Hairong Xiong, David F. Kisor, Randal Croshaw and Nancy G. Pedigo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of neurosurgery.

In The Last Decade

Christopher Farrell

24 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Farrell United States 8 131 70 70 39 38 27 272
Jennifer H. Benbow United States 11 114 0.9× 78 1.1× 38 0.5× 45 1.2× 40 1.1× 22 334
Andrew Brandmaier United States 13 143 1.1× 97 1.4× 62 0.9× 62 1.6× 35 0.9× 24 378
Raksha R. Bhat United States 11 125 1.0× 77 1.1× 42 0.6× 42 1.1× 58 1.5× 19 296
Karen van der Weide Netherlands 8 117 0.9× 56 0.8× 66 0.9× 16 0.4× 22 0.6× 11 324
Daniel C. Rohrer United States 8 115 0.9× 95 1.4× 64 0.9× 21 0.5× 100 2.6× 11 382
Antonietta Pia Gallo Italy 10 219 1.7× 74 1.1× 57 0.8× 30 0.8× 47 1.2× 12 343
Laia Trigueros‐Motos Spain 10 190 1.5× 81 1.2× 28 0.4× 19 0.5× 46 1.2× 11 335
Michaela Warich-Kirches Germany 11 200 1.5× 69 1.0× 76 1.1× 36 0.9× 18 0.5× 15 336
Hye Jung Baek South Korea 11 203 1.5× 100 1.4× 50 0.7× 59 1.5× 28 0.7× 19 320
Imrana Tanvir Pakistan 9 263 2.0× 78 1.1× 114 1.6× 31 0.8× 20 0.5× 33 400

Countries citing papers authored by Christopher Farrell

Since Specialization
Citations

This map shows the geographic impact of Christopher Farrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Farrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Farrell more than expected).

Fields of papers citing papers by Christopher Farrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Farrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Farrell. The network helps show where Christopher Farrell may publish in the future.

Co-authorship network of co-authors of Christopher Farrell

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Farrell. A scholar is included among the top collaborators of Christopher Farrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Farrell. Christopher Farrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Farrell, Christopher, et al.. (2024). Impact of Substance Use Disorder on Tryptophan Metabolism Through the Kynurenine Pathway: A Narrative Review. Metabolites. 14(11). 611–611. 3 indexed citations
4.
Farrell, Christopher, et al.. (2024). Gene Variant Frequencies of IDO1, IDO2, TDO, and KMO in Substance Use Disorder Cohorts. Genes. 15(11). 1388–1388. 1 indexed citations
5.
Farrell, Christopher, et al.. (2024). Exploring the Therapeutic Potential for Breast Cancer of Phytochemicals and Secondary Metabolites in Marjoram, Thyme, and Persimmon. Metabolites. 14(12). 652–652. 1 indexed citations
6.
Khanna, Omaditya, Michael P. Baldassari, Arbaz Momin, et al.. (2024). The effect of institutional case volume on post-operative outcomes after endarterectomy and stenting for symptomatic carotid stenosis. Journal of Stroke and Cerebrovascular Diseases. 33(9). 107828–107828. 3 indexed citations
7.
Smith, Hadley Stevens, et al.. (2024). Payer perspectives on genomic testing in the United States: A systematic literature review. Genetics in Medicine. 27(2). 101329–101329. 2 indexed citations
8.
Haldar, Debanjan, Adam Leibold, Kevin Hines, et al.. (2024). Introducing a novel hybrid educational boot camp to augment medical student training in neurosurgery. Journal of neurosurgery. 141(5). 1386–1394. 1 indexed citations
9.
Sarasua, Sara M., et al.. (2021). The impact of pharmacogenetic testing in patients exposed to polypharmacy: a scoping review. The Pharmacogenomics Journal. 21(4). 409–422. 17 indexed citations
10.
Kisor, David F. & Christopher Farrell. (2019). Expanding Pharmacist and Student Pharmacist Access to Genetics/Genomics/Pharmacogenomics Competency Education. SHILAP Revista de lepidopterología. 6. 2808453845–2808453845. 12 indexed citations
11.
Buckhaults, Phillip, et al.. (2016). Association of FGD1 polymorphisms with early-onset breast cancer. Oncology Letters. 12(3). 2071–2077. 4 indexed citations
12.
Pedigo, Nancy G., et al.. (2016). Minireview: Role of genetic changes of faciogenital dysplasia protein 1 in human disease. Physiological Genomics. 48(7). 446–454. 7 indexed citations
14.
Birtwistle, Marc R., Himel Mallick, Nengjun Yi, et al.. (2014). Transcriptomes and shRNA Suppressors in a TP53 Allele–Specific Model of Early-Onset Colon Cancer in African Americans. Molecular Cancer Research. 12(7). 1029–1041. 12 indexed citations
15.
Farrell, Christopher, et al.. (2014). Application of Genomic Principles to Pharmacotherapy of Cancer. American Journal of Pharmaceutical Education. 78(3). 55–55. 7 indexed citations
17.
Farrell, Christopher, Randal Croshaw, Sangeeta Kowli, et al.. (2009). A Gene Expression Classifier of Node-Positive Colorectal Cancer. Neoplasia. 11(10). 1074–IN12. 24 indexed citations
18.
Lin, Ying, Phillip Buckhaults, Jeffrey R. Lee, et al.. (2009). Association of the Actin-Binding Protein Transgelin with Lymph Node Metastasis in Human Colorectal Cancer. Neoplasia. 11(9). 864–IN5. 77 indexed citations
19.
Farrell, Christopher, et al.. (2008). Somatic mutations to CSMD1 in colorectal adenocarcinomas. Cancer Biology & Therapy. 7(4). 609–613. 35 indexed citations
20.
Aslan, Peter, et al.. (1997). SPLENO‐GONADAL FUSION OF THE TESTIS. Australian and New Zealand Journal of Surgery. 67(12). 899–900. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026